US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ObsEva SA

0.0001

0.0000

Volume:857.00

Turnover:0.09

Market Cap:11.70K

PE:0.00

High:0.0001

Open:0.0001

Low:0.0001

Close:0.0001

52wk High:0.0501

52wk Low:0.0000

Shares:117.00M

Float Shares:117.00M

Volume Ratio:0.11

T/O Rate:0.00%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.0738

EPS(LYR):-0.3245

ROE:1576.52%

ROA:10.05%

PB:0.00

PE(LYR):0.00

Loading ...

Overview Company News Filings

Company Profile

Company Name:

ObsEva SA

Exchange:

EXPERT

Establishment Date:

2012

Employees:

15

Office Location:

Chemin des Aulx, 12,Plan-les-Ouates,Geneva,Geneva,Switzerland

Website:

- -

Zip Code:

1228

Phone:

41 22 552 38 40

Fax:

- -

Introduction:

ObsEva SA, a biopharmaceutical company, focuses on the development of novel therapies to improve women's reproductive health. It develops Nolasiban, an oral oxytocin receptor agonist for improving clinical pregnancy and live birth rates in women undergoing in-vitro fertilization. ObsEva SA was founded in 2012 and is headquartered in Geneva, Switzerland.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/OBSEF/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"OBSEF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OBSEF\",,,,,undefined,":{"symbol":"OBSEF","market":"US","secType":"STK","nameCN":"ObsEva SA","latestPrice":0.0001,"timestamp":1765383049257,"preClose":0.0001,"halted":0,"volume":857,"delay":15,"floatShares":117000000,"shares":117000000,"eps":0.073847,"marketStatus":"Trading","change":0,"latestTime":"12-10 11:10:49 EST Delay","open":0.0001,"high":0.0001,"low":0.0001,"amount":0.0857,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":0.073847,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1765400400000},"marketStatusCode":2,"adr":0,"exchange":"EXPERT","adjPreClose":0.0001,"volumeRatio":0.109199},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OBSEF\",,,,,undefined,":{"symbol":"OBSEF","floatShares":117000000,"roa":"10.05%","roe":"1576.52%","lyrEps":-0.324486,"volumeRatio":0.109199,"shares":117000000,"dividePrice":0,"high":0.0001,"amplitude":0,"preClose":0.0001,"low":0.0001,"week52Low":0.000001,"pbRate":"0.00","psRate":"0.00","week52High":0.05005,"institutionHeld":0,"latestPrice":0.0001,"eps":0.073847,"divideRate":0,"volume":857,"delay":15,"ttmEps":0.073847,"open":0.0001,"prevYearClose":0.0001,"prevWeekClose":0.0001,"prevMonthClose":0.0001,"prevQuarterClose":0.0001,"fiveDayClose":0.0001,"twentyDayClose":0.0001,"sixtyDayClose":0.0001},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OBSEF\",params:#limit:5,,,undefined,":[{"date":"2024-04-30","symbol":"OBSEF","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1714464000000,"name":null,"time":"","dateTimestamp":1714449600000,"actualEps":null},{"market":"US","date":"2023-09-27","symbol":"OBSEF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1695787200000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OBSEF\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"OBSEF\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":245335894,"yearFounded":2012,"employeeNum":15,"address":"Chemin des Aulx, 12,Plan-les-Ouates,Geneva,Geneva,Switzerland","zipCode":"1228","officePhone":"41 22 552 38 40"},"stockCompanyDetail":{"description":"ObsEva SA, a biopharmaceutical company, focuses on the development of novel therapies to improve women's reproductive health. It develops Nolasiban, an oral oxytocin receptor agonist for improving clinical pregnancy and live birth rates in women undergoing in-vitro fertilization. ObsEva SA was founded in 2012 and is headquartered in Geneva, Switzerland.","exchange":"EXPERT","name":"ObsEva SA","nameEN":"ObsEva SA"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"OBSEF\",market:\"US\",,,undefined,":null}}